Elicera Therapeutics AB (publ) (FRA:8E8)
Germany
· Delayed Price · Currency is EUR 0.584
0.00 (0.00%)
Last updated: Dec 4, 2025, 8:02 AM CET
Elicera Therapeutics AB Revenue
Elicera Therapeutics AB had revenue of 7.91M SEK in the quarter ending September 30, 2025, with 3,285.70% growth. This brings the company's revenue in the last twelve months to 13.70M, up 219.62% year-over-year. In the year 2024, Elicera Therapeutics AB had annual revenue of 7.13M, down -36.52%.
Revenue (ttm)
13.70M SEK
Revenue Growth
+219.62%
P/S Ratio
23.21
Revenue / Employee
6.85M SEK
Employees
2
Market Cap
28.75M EUR
Revenue Chart
* This company reports financials in SEK.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |